Find, compare & contact
Isobromindione
API Manufacturers & Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Isobromindione API 1470-35-5?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Isobromindione. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Isobromindione
- Synonyms:
- Cas Number:
- 1470-35-5
- DrugBank number:
- DB13545
- Unique Ingredient Identifier:
- J1J87P409K
General Description:
Isobromindione is a chemical compound identified by the CAS number 1470-35-5. It is known for its distinct pharmacological properties and applications.
Classification:
Isobromindione belongs to the class of organic compounds known as indanediones. These are compounds containing an indane ring bearing two ketone groups, classified under the direct parent group Indanediones. This compound is a part of the Organic compounds, falling under the Benzenoids superclass, and categorized within the Indanes class, specifically within the Indanones subclass.
Categories:
Isobromindione is categorized under the following therapeutic classes: Antigout Preparations, Musculo-Skeletal System, Preparations Increasing Uric Acid Excretion. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Isobromindione is a type of Anti-inflammatory Agents
Anti-inflammatory agents are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) used to treat various inflammatory conditions. These agents play a vital role in alleviating pain, reducing swelling, and controlling inflammation in the body. They are widely employed in the management of diverse medical conditions, including arthritis, autoimmune disorders, asthma, and skin conditions like dermatitis.
Anti-inflammatory APIs primarily function by inhibiting the production of specific enzymes called cyclooxygenases (COX) and lipoxygenases (LOX). These enzymes are responsible for the synthesis of pro-inflammatory molecules known as prostaglandins and leukotrienes, respectively. By suppressing the activity of COX and LOX, anti-inflammatory agents effectively curtail the production of these inflammatory mediators, thereby mitigating inflammation.
Common examples of anti-inflammatory APIs include non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, aspirin, and naproxen. These agents exhibit analgesic, antipyretic, and anti-inflammatory properties. Another group of anti-inflammatory APIs includes corticosteroids, such as prednisone and dexamethasone, which are synthetic hormones that modulate the body's immune response to control inflammation.
In conclusion, anti-inflammatory agents are a vital category of pharmaceutical APIs widely used to manage inflammation-related disorders. They target enzymes involved in the synthesis of pro-inflammatory molecules, effectively reducing pain and swelling. NSAIDs and corticosteroids are commonly prescribed anti-inflammatory APIs due to their efficacy in controlling inflammation.
